Literature DB >> 11460505

Transcriptional control mechanism of fibrinogen gene expression.

G M Fuller1, Z Zhang.   

Abstract

Although fibrinogen genes are expressed constitutively in hepatocytes, their transcription can be greatly increased during inflammatory stress. Extensive studies have focused on the cytokine mediated transcriptional regulation of fibrinogen genes. It is clear that interleukin-6 (IL-6) and its family of cytokines are the major inducers of fibrinogen gene expression. Functional analyses of all three fibrinogen promoters for human and rat all demonstrate that the conserved CTGGGAA motifs within the proximal promoter of each fibrinogen gene are the IL-6 responsive elements. Exploration of the rat gamma fibrinogen gene demonstrated that the IL-6 activated transcription factor, STAT3, binds to the CTGGGAA motif and is required for the IL-6 mediated upregulation of this gene. IL-6 mediated fibrinogen production can be significantly elevated by glucocorticoid treatment. The synergistic effect of glucocorticoids and IL-6 relies on the functional interaction between STAT3 and glucocorticoid receptor. In addition to the upregulation signals for fibrinogen gene expression during inflammatory stress, other signaling also downregulates the expression of fibrinogen genes. For example, the proinflammatory cytokine IL-1 beta exerts inhibitory function on IL-6 mediated fibrinogen gene expression. Given the fact that elevated levels of fibrinogen in blood correlate with increased risk for cardiovascular disease, there is strong motivation to explore the molecular mechanisms that control fibrinogen expression, especially those signals that may downmodulate expression and thus provide novel approaches to controlling fibrinogen levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11460505     DOI: 10.1111/j.1749-6632.2001.tb03534.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  28 in total

1.  A liver enhancer in the fibrinogen gene cluster.

Authors:  Alexandre Fort; Richard J Fish; Catia Attanasio; Roland Dosch; Axel Visel; Marguerite Neerman-Arbez
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

2.  Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe).

Authors:  Christina L Wassel; Leslie A Lange; Brendan J Keating; Kira C Taylor; Andrew D Johnson; Cameron Palmer; Lindsey A Ho; Nicholas L Smith; Ethan M Lange; Yun Li; Qiong Yang; Joseph A Delaney; Weihong Tang; Geoffrey Tofler; Susan Redline; Herman A Taylor; James G Wilson; Russell P Tracy; David R Jacobs; Aaron R Folsom; David Green; Christopher J O'Donnell; Alexander P Reiner
Journal:  Blood       Date:  2010-10-26       Impact factor: 22.113

3.  Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response.

Authors:  Nicolas Venteclef; Jason C Smith; Bryan Goodwin; Philippe Delerive
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  Susceptibility to chronic thromboembolic pulmonary hypertension may be conferred by miR-759 via its targeted interaction with polymorphic fibrinogen alpha gene.

Authors:  Zhiyong Chen; Toshiaki Nakajima; Nobuhiro Tanabe; Kunihiko Hinohara; Seiichiro Sakao; Yasunori Kasahara; Koichiro Tatsumi; Yoshinori Inoue; Akinori Kimura
Journal:  Hum Genet       Date:  2010-07-31       Impact factor: 4.132

5.  FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma.

Authors:  Zhi Shang; Xiaomin Niu; Kewei Zhang; Zhi Qiao; Sha Liu; Xiaoteng Jiang; Chengxi Cao; Shun Lu; Hua Xiao
Journal:  J Mol Med (Berl)       Date:  2019-11-28       Impact factor: 4.599

6.  Dexamethasone induces connective tissue growth factor expression in renal tubular epithelial cells in a mouse strain-specific manner.

Authors:  Hirokazu Okada; Tomohiro Kikuta; Tsutomu Inoue; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masaharu Takigawa; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

7.  IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun.

Authors:  Yanchun Li; Devadoss J Samuvel; Kamala P Sundararaj; Maria F Lopes-Virella; Yan Huang
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

8.  Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study.

Authors:  Cara L Carty; Patrick Heagerty; Susan R Heckbert; Gail P Jarvik; Leslie A Lange; Mary Cushman; Russell P Tracy; Alexander P Reiner
Journal:  Ann Hum Genet       Date:  2010-01       Impact factor: 1.670

9.  Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.

Authors:  Florin L Craciun; Amrendra K Ajay; Dana Hoffmann; Janani Saikumar; Steven L Fabian; Vanesa Bijol; Benjamin D Humphreys; Vishal S Vaidya
Journal:  Am J Physiol Renal Physiol       Date:  2014-07-09

10.  Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.

Authors:  Mario Menschikowski; Albert Hagelgans; Ulrich Schuler; Susanne Froeschke; Andrea Rosner; Gabriele Siegert
Journal:  Pathol Oncol Res       Date:  2013-06-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.